Traditional pharmaceutical companies simply can’t afford to spend the $1 billion or more it takes to bring a drug all the way to market when the affected population is too poor to buy the drugs, or too small to make a dent in the investment. Organizations like SRI fill the gap.
According to a recent report by the President's Council on Jobs and Competitiveness, more than three million job openings in the U.S. go unfilled for months on end because most employers say they’re having difficulty finding and hiring qualified STEM workers. Let’s take a closer look.
There’s a common perception that people with Autism Spectrum Disorders (ASDs) are more likely than the general population to gravitate toward science, technology, engineering, and mathematics (STEM) fields. It turns out the perception is true.